Bloomington, Indiana (PRWEB) July 18, 2013
The Greater Bloomington Chamber of Commerce recently honored Alisa Wright, Founder and CEO of BioConvergence, a Bloomington-based contract manufacturing organization, with the Women Excel Bloomington (WEB) Award on July 9, 2013. The selection committee received a number of nominations and based final selection on “outstanding leadership and spirit in both the community and/or in their organization,” according to the Chamber’s related press release.
Wright’s industry experience began with Eli Lilly and Company, Cook Pharmaceutical Solutions, and Baxter Pharmaceutical Solutions and includes contributions to developing the first drug for pancreatic cancer, launching 50 clinical programs, and producing bio-defense vaccines and therapeutics for the U.S. government (including the first initiative following September 11, 2001), respectively.
After working for 25 years in large pharmaceutical and contract manufacturing organizations, she identified gaps in the industry and founded BioConvergence in an effort to help pharmaceutical and biotechnology companies streamline vendor management systems, mitigate risk, and move product to market, and to the patients in need... more quickly.
Throughout her career, Wright has actively participated in the community by offering her time to various lecturing and mentoring programs and serving on multiple advisory boards for surrounding academic institutions. She has also volunteered alongside organizations such as BioCrossroads and Indiana Health Industry Forum.
“Alisa’s broad expertise, acquired from a variety of diverse roles in the industry, has certainly played a significant role in her entrepreneurial achievements. But, her personal values, centered in
Copyright©2012 Vocus, Inc.
All rights reserved